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Prostate brachytherapy involves implanting radioactive seeds (I125 for instance) 
permanently in the gland for the treatment of localized prostate cancers  e.g. cT1c-T2a 
N0 M0 with good prognostic factors. Treatment planning and seed implanting are most 
often based on the intensive use of transrectal ultrasound (TRUS) imaging. This is not 
easy because prostate visualization is difficult in this imaging modality particularly as 
regards the apex of the gland and from an intra- and inter-observer variability 
standpoint. Radioactive seeds are implanted inside open interventional MR machines in 
some centres. Since MRI was shown to be sensitive and specific for prostate imaging  
whilst open MR is prohibitive for most centres and makes surgical procedures very 
complex, this work suggests bringing the MR virtually in the operating room with 
MRI/TRUS data fusion. This involves providing the physician with bi-modality images 
(TRUS plus MRI) intended to improve treatment planning from the data registration 
stage. The paper describes the method developed and implemented in the PROCUR 
system. Results are reported for a phantom and first series of patients. Phantom 
experiments helped characterize the accuracy of the process. Patient experiments have 
shown that using MRI data linked with TRUS data improves TRUS image segmentation  
especially regarding the apex and base of the prostate. This may significantly modify 
prostate volume definition and  have an impact on treatment planning.  
 
I. INTRODUCTION 
Prostate cancer is the most common cause of cancer in men in many countries including the 
European Community and NorthAmerica. 40209 cases were reported out of a 60 million 
population in France in 2002 [1] matching a standardized incidence of 75.3 (rate per 100000) 
and 10004 individuals subsequently died. Many options – careful watch, conventional or 
laparoscopic surgery, brachytherapy, conventional or conformal external radiotherapy 
including IMRT, focused ultrasound, cryosurgery, etc. – are available and based on a multi-
disciplinary approach with informed patient consents. Individual screening from blood 
analysis using PSA allows for increased detection of early and localized stages. Recent 
progresses tend towards improving local control whilst minimizing side effects.  
 
Using permanently placed radioactive seeds (a technique known as brachytherapy) back in the 
1970s produced initial results that were as good as those obtained with other radiotherapy 
techniques and presented low impotence risks or other side effects. However seeds were 
placed freehand during laparotomy at that time [2] and resulted in non-homogeneous 
irradiation where cold regions may have contributed to disappointing clinical results.  
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Treatment planning and seed implantation is now based on the intensive use of transrectal 
ultrasound imaging. A stepper is used to acquire parallel transverse images with constant 
inter-slice distance. Moreover, needle insertion through the perinea is made easier via a grid, 
also called template, rigidly connected to the TRUS probe. This improved clinical outcome 
but such an approach is still limited by two factors. Firstly, the prostate apex and base are 
sometimes difficult to visualize in the transverse TRUS images and, secondly, intra- and inter-
observers variations are very frequent in ultrasound image interpretation. These problems 
could possibly be solved with image processing automation. Results regarding prostate 
automatic segmentation [3] whilst encouraging are generally obtained for images of the 
prostate acquired rather far from its extremities and therefore easier to process.  
 
Whilst prostate imaging is still controversial, Magnetic Resonance Imaging (MRI) has a great 
potential. Its sensitivity and specificity have been demonstrated. Radioactive seeds are 
currently implanted inside an open interventional MR (iMRI) machine in a small number of 
centres [4]. Robots may also be used in conjunction with CT or MRI imaging for improved 
accuracy and increased possible trajectories [5]. Yet, iMRI is  prohibitive for most centres and 
makes surgical procedures much more complex. Moreover, even when using iMRI for 
prostate procedures (biopsy or brachytherapy), pre-operative MRI is also acquired because it 
provides enhanced image quality and is correlated with iMRI [6].  
 
The alternative solution suggested is “bringing the MR virtually” in the operating room using 
MRI/TRUS data fusion. This approach allows refining prostate localization in the TRUS 
images with MRI data acquired pre-operatively. A similar approach was developed for biopsy 
guidance by Kaplan et al [7]. Those authors suggested registering MRI to TRUS by matching 
six fiducial prostate points defined in both modalities. Whereas, for sake of accuracy and 
robustness improvement in data fusion, we elected to record large sets of 3D points. In the 
presented approach, contours segmented in the intra-operative TRUS data with a satisfactory 
level of confidence are used for registration. MRI data are then superimposed to TRUS 
images to verify and improve TRUS segmentation at the apex and base of the prostate in 
particular. The objective is to improve data acquisition, homogeneity of dosimetry with a 
better definition of the D90 isodose and  the reliability of urethra and rectum Dose Volume 
Histograms (DVH). This might help control cancer while reducing bladder, rectum and 
urethra side effects.  
 
II. MATERIAL AND METHODS 
Two types of protocols are used for prostate brachytherapy. The first is based on a pre-
planning stage whilst the treatment planning stage is taking place intra-operatively in the 
second one. The second protocol is that applied in our institution. 
 
A. Proposed method 
The PROCUR system presented in this paper is technically approached as follows. An MRI 
exam is performed with a transrectal coil and acquisition proceeds in the 3 orthogonal phases 
on the day preceding seed implantation. The patient is lying supine. Data are recorded in the 
DICOM format and transmitted to the computer for image processing. The contours of the 
prostate are manually segmented in the three planes. Data are segmented from the sagittal and 
coronal planes and superimposed onto those contours to facilitate apex segmentation in the 
MRI horizontal images. This step helps construct a three dimensional (3-D) cloud of n points, 
SMRI, representing the prostate in the MRI reference frame RMRI.  
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Intra-operatively, the patient is placed in the gynaecologic position. The TRUS probe is  
inserted and transverse images are collected regularly with a stepper as in the conventional 
procedure. The prostate is swept as a whole and approximatively 8 to 10 parallel images are 
collected. The urologist delineates the prostate on every image whenever possible. The data 
are then fed in the computer and the urologist segmentation is recorded. This results in a 
second set of m 3-D points, STRUS, representing the prostate in the ultrasound reference system 
RTRUS.  
 
The next stage involves registering both cloud points automatically. The system computes the 
TTRUS/MRI transform between RTRUS and RMRI allowing for optimal STRUS to SMRI 
superimposition. This is in fact minimizing the following energy as a function of the TTRUS/MRI 
unknown: 
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where MiTRUS is the ith point belonging to STRUS, σi is the estimated data-related error and SMRI 
represents the MRI data set. dist(S,P) is the Haussdorf distance between a point P and a 
surface S.  
 
A pre-registration consisting in superimposing the STRUS and SMRI centres of gravity initializes 
TTRUS/MRI before minimization. Two types of registration have been tested. In the first one 
called rigid registration, TTRUS/MRI is a homogeneous transform combining rotations and 
translations (6 parameters). The second one is an elastic registration  where TTRUS/MRI is much 
more complex allowing for rotation and translation between data sets as well as local 
deformations or distortions. Those methods are derived from the octree-spline elastic 
registration published by Szeliski and Lavallée [8]. The optimization procedure is the 
Levenberg-Marquardt algorithm (see [9]). Elastic registration makes use of an adaptive, 
hierarchical and regularized free-form deformation of one volume to the other coordinate 
system.  Since SMRI density is much higher than STRUS (n>>m), the octree-spline construction is 
based on SMRI. The result is a 3-D function fTRUS/MRI  transforming any point given in RTRUS to 
RMRI.  
 
Once the data have been registered (see figure 1) the software may compute the 
corresponding slice in the MRI transverse volume for every acquired TRUS image using 
fTRUS/MRI and the interpolation tools. An image presenting both the TRUS and MRI data is 
computed  to help the urologist visualize results and verify or improve prostate segmentation. 
The resulting image is split into four quadrants with a virtual cross: the upper right and lower 
left quadrants display TRUS data whilst the upper left and bottom right ones present the 
corresponding re-sliced MRI data (see figure 2). The users are allowed to move the cross in 
this bi-modality image. This representation helps them explore prostate limits in both 
modalities. Contours extracted from the MRI data  may also be superimposed to the TRUS 
images. MRI data help confirm or modify the original segmentation close to the apex and 
base of the prostate in particular. A 3-D representation is also available to the clinician. Three 
intersecting orthogonal MRI slices are computed in the three MRI volumes for any given 
needle i.e. a point defined in a transverse TRUS image at a normal direction to the image 
plane.    
 
This improved segmentation can then be used for treatment planning. The 3-D view may 
facilitate appreciating the needle position with respect to the whole gland and surrounding 
structures. 
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B.  Materials 
The MRI system is a Philips Gyroscan ACS II 1.5 Tesla operated with a transrectal coil. T2 
Turbo Spin Echo sequences are used for transverse, sagital and coronal acquisitions. The 
repetition time is 1800ms and echo time 120ms. The region explored is 15cmx15cm; image 
resolution is 256x256. The slice thickness is 3mm. The echographic system is a BK-Medical 
one. The stepper is designed to acquire TRUS images  every 5mm. The probe is a 8551 model 
(5-10Mhz intrarectal probe). The TRUS image size is 576x768 pixels. A tissue-equivalent 
ultrasound prostate phantom1 from CIRS (Computerized Imaging Reference Systems, Inc.) 
was used for technical evaluation and accuracy quantification. The PROCUR system is 
written in Visual C++. The computer is a PC Intel Pentium4, 1.6GHz with 256MB of RAM 
and equipped with a Matrox MeteorII video frame grabber. The PC is operated with 
Windows2000 Professional.  
 
C. Validation approach 
It must first be stated that treatment was planned and administered as usual to the patients 
participating in those evaluations. Imaging data (pre-operative MRI and intra-operative 
TRUS) were recorded. The PROCUR system was evaluated post-operatively from acquired 
data. Some evaluations were also performed with the phantom. 
 
1. Technical evaluation  
Registration is a key step in the PROCUR system. The registration methodology as presented 
in section II.1 involves minimizing the distance between two sets of 3-D points. It can be 
evaluated in several ways. Firstly, one can visually confirm that the two sets of points have a 
good fit. This evaluation is purely qualitative but should registration be poor, it may be useful 
to determine where mismatches were made. A second and more interesting qualitative 
computed transform evaluation is based on user interaction with the bi-modality image 
produced after data fusion. The continuity of prostate contours from one modality to the other 
is a very good indicator of registration quality.  
 
Quantitatively, information regarding the distance remaining between both sets of points is an 
indicator of registration quality. Mean, maximum, minimum values as well as standard 
deviations are reported in section III.1. However, small residual distances are not true 
equivalent of optimal registration and optimization algorithms may be trapped into local 
minima of the energy function. Pre-registration reduces this risk but it is not completely 
eliminated. A second registration accuracy assessment methodology consequently needs to be 
defined without any gold standard – the exact computed transform value cannot be 
determined – and it should be as minimally invasive as possible for the patients – i.e. avoiding 
marker placement as in [10] for instance. It was decided to verify the registration accuracy of 
the urethra. This is a significant structure in treatment planning; it is internal to the prostate 
and is not included in registration data. As far as the phantom is concerned, the urethra is 
easily visible in both modalities. It has to be visible for patients and this is why the procedure 
described below was adopted. A probe is inserted into the patient’s urethra and retained for 
the MRI examination as well as the implantation procedure the next day. This allows for 
urethra visibility in both MRI data and TRUS images. The PROCUR system is then operated  
as described in section II.A and produces a fTRUS/MRI value. The bi-modality image is 
computed for each echographic plane. The urethra position (lumen centre) is recorded  in the 
TRUS and MRI components for every bi-modality image (see figure 3). The distance between 
                                                 
1 Model 053 (see http:\\www.cirs.com) 
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those two points is computed. Mean, minimum, maximum values and standard deviations 
valid for phantom experiments and series of 4 patients are presented in section III.1  
 
2. Potential impact on treatment 
Other evaluations of a more clinically advanced level have also been performed. The effects  
resulting from the use of three orthogonal MRI acquisitions have been quantified for series of 
8 patients. The objective was to compare MRI transverse image segmentation with and 
without the assistance of the two other volumes. The effects of data fusion and MRI 
superimposition on prostate delineation were determined in two different manners. First, the 
number of contoured echographic images with and without data fusion have been compared 
close to the apex and to base of the gland for 11 patients. Secondly the prostate volume was 
computed without and with data fusion for the same patients. These data have a serious 
potential impact for the treatment planning stage. Results are presented in section III.2. 
 
A dose volume histogram (DVH)  was computed with the MRI-enhanced echographic data to 
predict the potential impact of volume modification on treatment outcome. It was compared to 
that applicable for the conventional procedure. A comparison is presented for one patient (No 
5).  
 
III. RESULTS 
III.1 Technical evaluation 
Phantom  
11 images of the phantom were obtained (see figures 4 and 5) with the TRUS probe 
(5.2MHz). Registration results are presented in table I. One can see a satisfactory match for 
prostate contours  in registered modalities (Fig. 5).  
 
Table I Residual distance error between STRUS and SMRI (mm) 
Registration method Mean [min; max] Std. Dev. 
Rigid 1.62 [0.34; 2.64] 0.40 
Elastic 1.07 [0.01; 2.75] 0.41 
 
The urethra match measurements on bi-modality images after registration are presented in the 
following table. These values correspond to the 11 bi-modality computed images of the 
phantom. Please note that the phantom urethra diameter is about 10mm. 
 
Table II Distance between the urethra detected 
on TRUS and on MRI (mm) 
Registration method Mean [min; max] Std. Dev. 
Rigid 1.30 [0.58; 2.63] 0.58 
Elastic 1.57 [0.82; 2.87] 0.62 
 
Rigid and elastic registrations are very similar because the phantom is non-deformable.  
 
Patients 
Table III reports results obtained for 11 patients.  
 
Table III Residual distance of the STRUS and SMRI surface points 
Patient  Rigid registration 
Mean [min; max] ± Std. Dev. 
Elastic registration 
Mean [min; max] ± Std. Dev. 
1  1.48 [0.84; 2.12] ± 0.27 1.13 [0.09; 4.03] ± 0.54 
2  1.58 [0.63; 2.59] ± 0.39 1.26 [0.10; 5.68] ± 0.76 
3  1.33 [0.73; 1.93] ± 0.23 0.95 [0.07; 2.79] ± 0.46 
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4  1.29 [0.50; 2.28] ± 0.30 1.08 [0.13; 4.00] ± 0.53 
5  1.31 [0.43; 2.24] ± 0.37 1.03 [0.07; 6.51] ± 0.59 
6  1.30 [0.73; 1.80] ± 0.22 1.09 [0.15; 3.08] ± 0.44 
7 1.38 [0.72; 2.09] ± 0.25 1.09 [0.06; 2.48] ± 0.40 
8 1.25 [0.65; 1.81] ± 0.25 1.09 [0.04; 3.25] ± 0.46 
9 1.32 [0.44; 2.25] ± 0.33 1.21 [0.09; 4.91] ± 0.57 
10 1.25 [0.42; 2.29] ± 0.37 1.07 [0.11; 2.60] ± 0.44 
11 1.42 [0.19; 3.22] ± 0.51 1.17 [0.09; 5.20] ± 0.76 
Average patient 1.36 [0.57; 2.24] ± 0.22 1.11 [0.09; 4.05] ± 0.54 
 
The verification on urethra (lumen centre) is reported in table IV for 4 out of these 11 
patients. The diameter of the urethra is 5 mm approximately. 
 
Table IV Distance between the urethra detected 
on TRUS and on MRI (mm) 
Patient  Rigid registration 
Mean [min; max] ± Std. Dev. 
Elastic registration 
Mean [min; max] ± Std. Dev. 
5 3.68 [1.39; 6.17] ± 1.89 2.05 [0.31; 3.77] ± 1.50 
6 3.52 [0.46; 9.24] ± 3.24 2.96 [0.46; 8.25] ± 3.06 
7 3.53 [0.49; 3.53] ± 1.00 1.51 [0.46; 2.19] ± 0.67 
9 2.03 [0.16; 5.71] ± 1.67 1.73 [0.56; 3.70] ± 1.04 
Average patient 2.90 [0.62; 6.16] ± 1.95 2.07 [0.45; 4.48] ± 1.57 
 
In Figure 6, the urethra distance is presented as a function of the slice number. Each curve 
corresponds to one patient. It clearly appears that errors are systematically higher for apical 
images and decrease fairly regularly. This will be discussed in section IV. Figure 7 shows the 
average urethra distance obtained for each slice and all 4 patients. 
 
III.2 Pre-clinical evaluation 
MRI segmentation 
Sagital and coronal MRI acquisitions helped increase the number of segmented slices in the 
MRI horizontal plane (see table V). On average, 1.12 slices representing 9.78% could be 
segmented additionally for the prostate base. 1.62 slice representing 14.13% were added for 
the apex. 
 
Table V Contribution of the sagittal and coronal MRI data to the 
segmentation of the prostate on the transverse MRI volume  
Patient number Nb of segmented 
transverse slices 
Nb of additional 
slices (base) 
Nb of additional 
slices (apex) 
1 10 2 1 
2 10 1 0 
3 14 1 2 
4 11 1 2 
5 14 0 3 
6 13 1 2 
7 10 1 2 
8 10 2 1 
Mean 11.5 1.125 1.625 
% - 9.78% 14.13% 
 
TRUS segmentation 
Using MRI data resulted in a modification of the number of segmented TRUS transverse 
images (see table VI): slices were added (or removed) for 4 (respectively 1) of the 11 patients  
i.e. 36.16% (or 9.1% respectively) of the cases. The base segmentation was modified for 5 of 
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the 11 patients i.e. 45.45% of the cases. The apex segmentation was modified for 4 of the 11 
patients i.e. 36.36% of the cases. Figure 8 shows a case where the prostate apex was not 
segmented on TRUS; MRI data provided additional information and enabled contour 
definition. 
 
Table VI Contribution of MRI data to the segmentation of apex and base  
of the prostate on TRUS images 
After registration (number of images added or removed) 
Apex Base 
Patient number Before 
registration 
Rigid Elastic Rigid Elastic 
1 11 0 0 0 0 
2 12 -1 0 -2 -1 
3 8 0 0 0 0 
4 8 0 0 0 0 
5 7 0 0 0 0 
6 8 0 0 0 0 
7 8 0 0 1 1 
8 5 1 1 1 1 
9 10 0 0 0 0 
10 7 0 1 1 1 
11 9 2 1 2 1 
27.27% of the 
cases 
27.27% 45.45% 45.45% Modified 
segmentation 
- 
36.36% 45.45% 
 
Volume measurement 
Prostate volume was measured for the original TRUS segmentation and modified 
segmentation resulting from MRI enhancement in each patient. The following formula was 
applied to compute this volume:  
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Where n is the number of slices, Si the surface of the ith slice and d the inter-slice distance. 
 
As regards the phantom, the volume corresponding to the original segmentation is 65.92cc; it 
is 67.97cc after elastic registration and MRI-enhancement. This corresponds to a difference of 
2.05cc and is equivalent to 3.11% of the original volume. It was not possible to compare these 
computed volumes with the real one because the dimensions given by the phantom provider 
are averages only. The difference between those two values mainly comes from the 
significant increase in surface (5.94cm2) of the first slice (apex) for which contour detection 
on the original TRUS image proved very difficult. In absolute (or signed) values, the surface 
difference (cf. figure 9) is: max = 5.94cm2, min = 0.05cm2, mean = 1.01cm2, std.dev. = 
1.69cm2 (max = 5.94cm2, min = -0.66cm2, mean = 0.63cm2, std.dev. = 1.88cm2 respectively).  
 
As can be seen on figure 10, the volume computed from enhanced images after elastic 
registration is higher than the original volume for all patients. In terms of percentage  
variation relatively to the initial volume, the minimum, maximum, mean values and the 
standard deviations are: min = 1.03% (patient No 6), max = 48.24% (patient No 8), mean 
=15.86%, std. dev. = 13.57%. The largest three volume differences (patients No 7, 8 and 10) 
correspond to cases where one additional echographic image was segmented after registration 
(see table VI). Concerning the other two patients (No 2 and 11) for whom the number of 
echographic images changed, the volume difference is lower. As regards patient No 2, the 
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removed slice is compensated in terms of volume by an increase  in computed surfaces on the 
other slices. As regards patient No 11, the added slice is partly compensated by the fact that 
the largest surface (slice No 5) is smaller in modified data compared to the original ones. 
 
Dose volume histograms 
Planned treatment in clinical practice is such that 90% of prostate volume should receive 
between 160 and 180Gy. The D90 planned on the original segmented contours of patient No 5 
corresponds to 165Gy i.e. 90% of the prostate is supposed to receive at least 165Gy. When the 
D90 is recomputed from modified contours after elastic registration, the corresponding value 
is 105Gy (i.e. 90% of the prostate is supposed to receive at least 105Gy). 68.45% only of the 
prostate would receive at least 165Gy for these modified contours. The difference between 
those two values is very significant (-36%). However, this is an individual test from which no 
conclusion can be drawn. Still, as pointed out in [11], image processing may significantly 
contribute to inaccuracy of dose distribution and measurement. Our results are very 
preliminary but they show that a significant difference in TRUS prostate definition coming 
from MRI enhancement may have a very large impact on potential clinical outcomes.  
 
IV. DISCUSSION AND CONCLUSION 
Concerning surface registration, qualitative results based on visual evaluation are generally 
quite positively appreciated from a clinician’s standpoint. Quantitative results are close to 
1mm in average and this is very satisfactory as the different sources of errors (image 
resolution, manual segmentation2) are taken into consideration. Rigid and elastic registrations 
give rather similar results in terms of residual distance measurements for both sets of points. It 
is likely that the rather similar positions of the patient during MRI and TRUS acquisition, 
which both involve placing an intra-rectal sensor, result in rather similar deformations of the 
prostate, if any. Prostate motion depending on bladder and rectum filling are ideally taken into 
account  with rigid registration. Elastic registration produces lower mean and minimum values 
as regards the residual distance between data, but the standard deviation and maximum 
residual distance are somewhat higher. This can be explained by the fact that elastic 
registration  imposes regularization to retain surface smoothness. This means that reducing the 
distance of one TRUS point closer to the MRI surface may increase the distance of an 
adjacent TRUS point to retain the TRUS surface continuity. Elastic registration will be the 
preferred methodology because it may render potential deformations. Both processes are real-
time ones.  
 
Our method differs from [7] on several accounts: the density of registered data (6 points 
versus large data sets) and the type of registration (point-to-point versus set-to-set and rigid 
versus rigid or elastic). The accuracy of small data sets point-to-point matching is highly 
dependent on the ability to precisely define the corresponding points in both modalities.  
However, the approach presented in [7] helps simplify the protocol. In the PROCUR system, 
the fact that contours are used without any need for explicit point-to-point equivalence 
between MRI and TRUS data has a related cost i.e. MRI prostate segmentation (TRUS 
segmentation is a standard stage in brachytherapy protocols). No quantitative comparison can 
be made with our work since no quantitative results are provided in reference [7]. 
 
As regards urethra experiments, figures 6 and 7 clearly show that measurements are 
dependent on the TRUS slice position for the patients. The distance measured between  both 
modalities is always higher close to the apex. This may be partly explained by the fact that the 
                                                 
2 In MRI images where pixel size is 0.58mm x 0.58mm for instance, a variation of 2 pixels in manual 
segmentation  is equivalent to a 1.16mm distance on the contour ..  
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TRUS apex slices often are the smallest surfaces and the most difficult to read. The 
uncertainty regarding urethra position is certainly a factor contributing to this error. 
Moreover, defining the lumen centre manually may be somewhat difficult and perhaps 
inaccurate even for a ‘satisfactory’ TRUS image. Errors are much smaller with the phantom  
because the urethra boundary is much more visible on TRUS images. A semi-automated 
procedure would probably reduce the centre localization inaccuracy. Those results do not 
seem to be correlated to the quality of surface registration but this would have to be confirmed  
with statistical analysis for a larger number of cases. Reference [12] describes CT/MRI 
registration for dose evaluation using urethral catheters. The authors underline that the least 
precise results were obtained near the prostate base and this is explained by potential balloon 
buoyancy. Concerning our experiments, the potential variability of urethral probe traction 
between MRI acquisition and the intra-operative situation could only be a low contributor to 
those results. One can also observe that our results globally improved from patient to patient 
and that may have been a learning curve effect for the placement of the urethral probe in a 
stable position. This should be confirmed with a significant number of cases. 
 
We demonstrated with series of 8 patients that using three MRI volumes acquisition facilitates 
prostate segmentation for the apical region and the base in particular. We also demonstrated 
that MRI enhancement allows modifying the number of segmented TRUS images especially  
at the apex and base of the prostate. Experiments made regarding volume measurements have 
shown that MRI enhancement always results in computed volume increases. The formula 
used for volume computation may be discussed and different expressions could be used (a 
simple average for two successive slices or a formula taking into account the fact that a 
prostate section may be unreported before the first slice and after the last one because of 
TRUS step or MRI inter-slice distance – both were experimented). However, general 
conclusions can be drawn because the formulae used for TRUS and MRI-enhanced images 
are identical. We have seen that underestimating the prostate volume in the TRUS data could 
have a very significant potential impact on dose distribution. This  needs to be confirmed with 
a clinical evaluation intended to correlate clinical factors (post-brachytherapy PSA 
measurements for instance) with those simulations.  
 
The next project stage is the clinical evaluation. Other long-term extensions could also be 
envisioned. Introducing MRI affords extensive opportunities. Several centres are attempting 
to evaluate its potential use in cancer localization (see reference [13] for instance) and this 
would allow for more precise and selective seeds positioning. In the same vein, seed 
placement could be based on MRI navigation with pre-operative data as brain and spine 
surgeons have been doing for many years now [14,15].  
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Figure 1: Data superimposition after registration 
 
 
       
 
Figure 2: Data fusion: the computed image presents MRI (top-left/bottom-right) data and 
TRUS data (top-right/bottom-left) for a given TRUS acquisition plane. Two examples. 
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Figure 4: Prostate TRUS phantom: (left) photograph (right) inside. 
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Figure 5: Phantom experiment: (a) MRI image – (b) TRUS image – (c) composite image after 
data fusion 
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Figure 6: Urethra distance with elastic registration. Each curve corresponds to one patient or 
the phantom. 
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Figure 7: Mean residual distance of the urethra 
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Figure 8: Segmentation of the apical region: (a) original non segmented TRUS image – (b) 
corresponding MRI recomputed slice – (c) contours from the MRI volumes (blue for frontal, 
yellow for sagittal and red for transverse) 
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Figure 9 : Surface analysis (phantom) : elastic registration. 
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Figure 10: Volume analysis (patients): elastic registration case 
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